Tekscan





Company Headquarters

307 West First St.
Boston, Massachusetts 02127
United States

Buyer's Guide

    Related Content

    • Extremities
      FDA Clears Tyber Medical

      FDA Clears Tyber Medical's All-in-One Extremity Joint Fixation Device

      Eliminates the use of the ancillary instrumentation for a wide range of bone fixation procedures.
      PR Newswire 07.13.17

    • Bracing/Prosthetics | MIS/Robotics
      Reaching the Optimal Gait Assistance of Exoskeletons

      Reaching the Optimal Gait Assistance of Exoskeletons

      The novel approach applied a wide range of exoskeleton behaviors while the user walked on a treadmill.
      Ghent University 06.26.17

    • Zimmer Biomet Resolves FDA Warning Letter for China Facility

      Zimmer Biomet Resolves FDA Warning Letter for China Facility

      Warning Letter related to Zhejiang, China manufacturing facility has been closed out.
      PR Newswire 06.15.17


    • Extremities
      Innovation With Speed

      Innovation With Speed

      A product development company's take on the global extremities market.
      Michael Barbella, Managing Editor 06.05.17

    • Spine Wave Hires Executive VP of Research and Development

      New manager hails from Zimmer Biomet.
      Marketwired 04.17.17

    • Instruments | MIS/Robotics | Trauma/Sports
      Minimally Invasive Fiber Optic Tool Measures Muscle Impairment

      Minimally Invasive Fiber Optic Tool Measures Muscle Impairment

      The technique could enable the complete 3D reconstruction of sarcomere proteins for studying muscle diseases.
      Cell Press 03.01.17


    • AdvaMed and MassMEDIC:  Two Meetings You Should Attend in 2017

      AdvaMed and MassMEDIC: Two Meetings You Should Attend in 2017

      ...
      Maria Shepherd, President and Founder, Medi-Vantage 02.23.17

    • Biologics
      SurgaColl Technologies Appoints CEO

      SurgaColl Technologies Appoints CEO

      William Allan previously held positions at Smith & Nephew, Angiodynamics, Orthovita, and Stryker.
      PR Newswire 01.16.17